Braslyn Ltd. Mirati Therapeutics, Inc. (MRTX) insider trading activity

MRTX Quotes by TradingView

Braslyn Ltd. is > 10% Shareholder of Mirati Therapeutics, Inc.. Currently has a direct ownership of 3.14 Million shares of MRTX, which is worth approximately $0. The most recent transaction as insider was on Mar 10, 2021, when has been sold 410 shares (Common Stock) at a price of $196.38 per share, resulting in proceeds of $80,516. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.14M
0% 3M change
0% 12M change
Total Value Held $0

Braslyn Ltd. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 10 2021
SELL
Open market or private sale
$80,516 $196.38 p/Share
410 Reduced 0.01%
3,135,966 Common Stock
Mar 10 2021
BUY
Exercise of conversion of derivative security
-
410 Added 0.01%
3,135,967 Common Stock
Mar 09 2021
SELL
Open market or private sale
$2,348,710 $196.2 p/Share
11,971 Reduced 0.38%
3,135,966 Common Stock
Mar 09 2021
BUY
Exercise of conversion of derivative security
-
11,971 Added 0.38%
3,135,967 Common Stock
Oct 29 2020
SELL
Open market or private sale
$22,194,754 $212.26 p/Share
104,564 Reduced 3.33%
3,031,402 Common Stock
Oct 29 2020
SELL
Payment of exercise price or tax liability
$202 $202.25 p/Share
1 Reduced 0.0%
3,135,966 Common Stock
Oct 29 2020
BUY
Exercise of conversion of derivative security
-
104,565 Added 3.23%
3,135,967 Common Stock
Oct 28 2020
SELL
Open market or private sale
$61,270,472 $207.39 p/Share
295,436 Reduced 9.42%
2,840,530 Common Stock
Oct 28 2020
SELL
Payment of exercise price or tax liability
$418 $209.16 p/Share
2 Reduced 0.0%
3,135,966 Common Stock
Oct 28 2020
BUY
Exercise of conversion of derivative security
-
295,438 Added 8.61%
3,135,968 Common Stock
Jun 12 2020
SELL
Open market or private sale
$41,400,000 $69.0 p/Share
600,000 Reduced 19.13%
2,535,966 Common Stock
Jun 12 2020
SELL
Payment of exercise price or tax liability
$436 $72.8 p/Share
6 Reduced 0.0%
3,135,966 Common Stock
Jun 12 2020
BUY
Exercise of conversion of derivative security
-
600,006 Added 16.06%
3,135,972 Common Stock
Mar 01 2019
SELL
Open market or private sale
$18,975,000 $69.0 p/Share
275,000 Reduced 8.77%
2,860,966 Common Stock
Mar 01 2019
SELL
Payment of exercise price or tax liability
$291 $72.8 p/Share
4 Reduced 0.0%
3,135,966 Common Stock
Mar 01 2019
BUY
Exercise of conversion of derivative security
-
275,004 Added 8.06%
3,135,970 Common Stock

Also insider at

INSG
INSEEGO CORP. Technology
> 10% Shareholder
BL

Braslyn Ltd.

> 10% Shareholder
New Providence, C5

Track Institutional and Insider Activities on MRTX

Follow Mirati Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRTX shares.

Notify only if

Insider Trading

Get notified when an Mirati Therapeutics, Inc. insider buys or sells MRTX shares.

Notify only if

News

Receive news related to Mirati Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MRTX